File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A Pan-Cancer review of ALK mutations: Implications for Carcinogenesis and Therapy

TitleA Pan-Cancer review of ALK mutations: Implications for Carcinogenesis and Therapy
Authors
KeywordsAcquired resistance
ALK inhibitor sensitivity
ALK mutations
Oncogenic activation
Issue Date2015
Citation
Current Cancer Drug Targets, 2015, v. 15 n. 4, p. 327-336 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/211901

 

DC FieldValueLanguage
dc.contributor.authorYau, NKM-
dc.contributor.authorFong, AY-
dc.contributor.authorLeung, HF-
dc.contributor.authorVerhoeft, KR-
dc.contributor.authorLim, QY-
dc.contributor.authorLam, WY-
dc.contributor.authorLui, WYV-
dc.date.accessioned2015-07-21T02:15:24Z-
dc.date.available2015-07-21T02:15:24Z-
dc.date.issued2015-
dc.identifier.citationCurrent Cancer Drug Targets, 2015, v. 15 n. 4, p. 327-336-
dc.identifier.urihttp://hdl.handle.net/10722/211901-
dc.languageeng-
dc.relation.ispartofCurrent Cancer Drug Targets-
dc.subjectAcquired resistance-
dc.subjectALK inhibitor sensitivity-
dc.subjectALK mutations-
dc.subjectOncogenic activation-
dc.titleA Pan-Cancer review of ALK mutations: Implications for Carcinogenesis and Therapy-
dc.typeArticle-
dc.identifier.emailLui, WYV: vlui002@hku.hk-
dc.identifier.authorityLui, WYV=rp01876-
dc.identifier.doi10.2174/1568009615666150225123712-
dc.identifier.scopuseid_2-s2.0-84930739822-
dc.identifier.hkuros245623-
dc.identifier.volume15-
dc.identifier.issue4-
dc.identifier.spage327-
dc.identifier.epage336-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats